{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T20:57:39Z","timestamp":1775768259814,"version":"3.50.1"},"reference-count":0,"publisher":"Portico","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1358\/dot.2018.54.3.2776625","type":"journal-article","created":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T03:40:23Z","timestamp":1525750823000},"page":"187","source":"Crossref","is-referenced-by-count":14,"title":["Axicabtagene ciloleucel for the treatment of relapsed\/refractory\nB-cell non-Hodgkin's lymphomas"],"prefix":"10.3730","volume":"54","author":[{"family":"Sharma, P.","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"King, G.T.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Shinde, S.S.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Purev, E.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Jimeno, A.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1320","published-online":{"date-parts":[[2018]]},"container-title":["Drugs of Today"],"original-title":[],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T13:32:03Z","timestamp":1685453523000},"score":1,"resource":{"primary":{"URL":"http:\/\/access.portico.org\/stable?au=pjbf7ddpnm6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":0,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1358\/dot.2018.54.3.2776625","relation":{},"ISSN":["1699-4019"],"issn-type":[{"value":"1699-4019","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}